Skip to main content
Journal ArticleOPEN ACCESS

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

  • Skoulidis F
  • Li B
  • Dy G
  • et al.
New England Journal of Medicine (2021) 384(25) 2371-2381
DOI: 10.1056/nejmoa2103695
1.0kCitations
Citations of this article
833Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background Sotorasib showed anticancer activity in patients with KRAS p.G12C–mutated advanced solid tumors in a phase 1 study, and particularly promising anticancer activity was observed i...

Cite

CITATION STYLE

APA

Skoulidis, F., Li, B. T., Dy, G. K., Price, T. J., Falchook, G. S., Wolf, J., … Govindan, R. (2021). Sotorasib for Lung Cancers with KRAS p.G12C Mutation. New England Journal of Medicine, 384(25), 2371–2381. https://doi.org/10.1056/nejmoa2103695

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free